CAPCHEM (300037.SZ): CSRC issues overseas listing filing notice, up to 96,329,900 shares planned
NewTimeSpace News: On 13 November 2026, the International Cooperation Department of the China Securities Regulatory Commission (CSRC) disclosed that Shenzhen Capchem Technology Co., Ltd. (300037.SZ) has obtained CSRC filing for its overseas offering and listing. According to the filing notice, the Company proposes to issue not more than 96,329,900 overseas-listed ordinary shares and to list them on the Stock Exchange of Hong Kong.
The notice sets out three requirements: from the date of issue until completion of the overseas offering and listing, the Company shall report any material matters through the CSRC's filing management information system in accordance with the relevant provisions on overseas offerings and listings by domestic enterprises; within 15 working days after completion, the Company shall report the offering and listing through the same system and strictly comply with the relevant domestic and overseas laws, regulations and rules during the process; and if the offering and listing is not completed within 12 months from the date of issue and the Company intends to continue to pursue it, it shall update its filing materials.
The notice states that it only confirms the filing information for the overseas offering and listing and does not indicate that the CSRC has made any substantive judgment or guarantee on the investment value of the enterprise's securities or investors' returns, nor does it indicate that the CSRC guarantees or affirms the truthfulness, accuracy and completeness of the enterprise's filing materials.
- Capchem(300037.SZ) gets CSRC filing for H-share listing of up to 96,329,900 shares
- Capchem files updated prospectus with HKEX; electronics chemicals and functional materials provider with CITIC Securities and CICC as joint sponsors
- CAPCHEM HKEX IPO Application Lapsed; World’s No.1 Capacitor Chemicals Producer for Five Consecutive Years, Leading Domestic Organic Fluorine Supplier
- AB&B BIO-TECH-B (02627.HK): Adsorbed Tetanus Vaccine Wins CDE IND Clearance
- BOCOM INTL (03329.HK): Buys US$12m Standard Chartered Notes for HK$93.6m